Quetiapine

Quetiapine tablets and extended-release (long-acting) tablets are used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Quetiapine tablets and extended-release tablets are also used alone or with other medications to treat episodes of mania (frenzied, abnormally excited or irritated mood) or depression in patients with bipolar disorder (manic depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). In addition, quetiapine tablets and extended-release tablets are used with other medications to prevent episodes of mania or depression in patients with bipolar disorder. Quetiapine extended-release tablets are also used along with other medications to treat depression. Quetiapine tablets may be used as part of a treatment program to treat bipolar disorder and schizophrenia in children and teenagers. Quetiapine is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.

Quetiapine comes as a tablet and as an extended-release tablet to take by mouth. The tablets are usually taken one to three times a day with or without food. The extended-release tablets are usually taken once a day in the evening without food or with a light meal. Take quetiapine at around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take quetiapine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Swallow quetiapine extended-release tablets whole; do not split, chew, or crush them.

Your doctor will probably start you on a low dose of quetiapine and gradually increase your dose during the first week of your treatment. Ask your doctor or pharmacist if you have any questions about the amount of medication you should take each day at the beginning of your treatment.

If you do not take quetiapine for one week or longer, you should call your doctor before you start taking the medication again. Your doctor will probably tell you to start taking a low dose of the medication and gradually increase your dose as you did when you first started taking quetiapine.

Quetiapine may help control your symptoms but will not cure your condition. Continue to take quetiapine even if you feel well. Do not stop taking quetiapine without talking to your doctor. If you suddenly stop taking quetiapine, you may experience withdrawal symptoms such as nausea, vomiting, and difficulty falling asleep or staying asleep. Your doctor will probably want to decrease your dose gradually.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking quetiapine,

• tell your doctor and pharmacist if you are allergic to quetiapine, any other medications. or any of the ingredients in quetiapine tablets or extended-release tablets. Ask your doctor or pharmacist or check the Medication Guide for a list of the ingredients.

• tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements and herbal products you are taking or plan to take. Be sure to mention any of the following: antidepressants; certain antifungals such as fluconazole (Diflucan), itraconazole (Onmel, Sporanox), ketoconazole (Nizoral), and voriconazole (Vfend); antihistamines; barbiturates such as phenobarbital; carbamazepine (Tegretol); chlorpromazine; divalproex (Depakote); certain medications for irregular heartbeat such as amiodarone (Nexterone), procainamide, quinidine, and sotalol (Betapace, Betapace AF, Sorine); dopamine agonists such as bromocriptine (Parlodel), cabergoline (Dostinex), levodopa (Dopar, Larodopa), pergolide (Permax), and ropinirole (Requip); erythromycin (E.E.S., E-Mycin, Erythrocin); gatifloxacin (Zymar, Zymaxid); levodopa (in Parcopa, in Sinemet, in Stalevo); levomethadyl acetate (Orlaam) (not available in the U.S.), medications for anxiety, high blood pressure, irritable bowel disease, mental illness, motion sickness, Parkinson's disease, ulcers, or urinary problems; medications for human immunodeficiency virus (HIV) such as indinavir (Crixivan), nelfinavir (Viracept), ritonavir (Norvir, in Kaletra), and saquinavir (Invirase); methadone (Dolophine, Methadose); moxifloxacin (Avelox, Moxeza, Vigamox); pentamidine (Nebupent, Pentam); phenytoin (Dilantin); rifampin (Rifadin, Rimactane); sedatives; oral steroids such as dexamethasone, methylprednisolone (Medrol), and prednisone (Rayos); sleeping pills; thioridazine (Mellaril); tranquilizers; and ziprasidone (Geodon). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

• tell your doctor if you or anyone in your family has or has ever had diabetes or a prolonged QT interval (a rare heart problem that may cause irregular heartbeat, fainting, or sudden death). Also tell your doctor if you have ever used street drugs or overused prescription medications. Tell your doctor if you have or have ever had a low level of potassium or magnesium in your blood, a low number of white blood cells, are unable to completely empty your bladder, any condition that makes it difficult for you to swallow, trouble keeping your balance, seizures, cataracts, high cholesterol, high prolactin levels, an enlarged prostate, high or low blood pressure, a heart attack, a stroke, breast cancer or thyroid, heart or liver disease. Tell your doctor if you have constipation, severe vomiting, diarrhea or signs of dehydration now, or if you develop these symptoms at any time during your treatment. Also, if you have ever had to stop taking a medication for mental illness because of severe side effects, be sure to tell your doctor.

• tell your doctor if you are pregnant, especially if you are in the last few months of your pregnancy, or if you plan to become pregnant or are breastfeeding. If you become pregnant while taking quetiapine, call your doctor. Quetiapine may cause problems in newborns following delivery if it is taken during the last months of pregnancy. You should not breastfeed while taking quetiapine.

• you should know that this medication may decrease fertility in women. Talk to your doctor about the risks of taking quetiapine.

• if you are having surgery, including dental surgery, tell your doctor or dentist that you are taking quetiapine.

• you should know that quetiapine may make you drowsy. Do not drive a car or operate machinery and take precautions to avoid falls until you know how this medication affects you.

• you should know that alcohol can add to the drowsiness caused by this medication. Do not drink alcohol while taking quetiapine.

• you should know that you may experience hyperglycemia (increases in your blood sugar) while you are taking this medication, even if you do not already have diabetes. If you have schizophrenia, you are more likely to develop diabetes than people who do not have schizophrenia, and taking quetiapine or similar medications may increase this risk. Tell your doctor immediately if you have any of the following symptoms while you are taking quetiapine: extreme thirst, frequent urination, extreme hunger, blurred vision, or weakness. It is very important to call your doctor as soon as you have any of these symptoms, because high blood sugar can cause a serious condition called ketoacidosis. Ketoacidosis may become life-threatening if it is not treated at an early stage. Symptoms of ketoacidosis include: dry mouth, nausea and vomiting, shortness of breath, breath that smells fruity, and decreased consciousness.

• you should know that quetiapine may make it harder for your body to cool down when it gets very hot. While you are taking quetiapine, you should avoid excessive exercise, stay inside as much as possible and dress lightly in hot weather, stay out of the sun, and drink plenty of fluids.

• you should know that quetiapine may cause dizziness, lightheadedness, and fainting when you get up too quickly from a lying position. This is more common when you first start taking quetiapine and when your dose is increased. To avoid this problem, get out of bed slowly, resting your feet on the floor for a few minutes before standing up.

• you should know that quetiapine may cause an increase in blood pressure in children and teenagers taking quetiapine. When quetiapine is used in children or teenagers, your doctor will check your blood pressure before starting treatment and regularly while you are taking this medication.

• you should know that when quetiapine is used to treat schizophrenia or bipolar disorder in children, it should be used as part of a total treatment program which may include counseling and special education. Make sure to follow all of your doctor's and/or therapist's instructions.

Talk to your doctor about eating grapefruit and drinking grapefruit juice while taking this medicine.

You should know that you may gain weight while you are taking this medication. Talk to your doctor about ways to control weight gain, such as eating a healthy, balanced diet and exercising. You and your doctor should check your weight regularly while you are taking quetiapine.

Be sure to drink plenty of water every day while you are taking this medication.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

• Quetiapine may cause side effects. Tell your doctor if any of these symptoms or those listed in the SPECIAL PRECAUTIONS section are severe or do not go away:

  • dizziness, feeling unsteady, or having trouble keeping your balance

  • pain in the joints, back, neck, or ears

  • weakness

  • dry mouth

  • vomiting

  • indigestion

  • constipation

  • gas

  • stomach pain or swelling

  • increased appetite

  • excessive weight gain

  • stuffy nose

  • headache

  • pain

  • irritability

  • difficulty thinking or concentrating

  • difficulty speaking or using language

  • loss of coordination

  • unusual dreams

  • numbness, burning, or tingling in the arms or legs

  • missed menstrual periods

  • breast enlargement in males

  • discharge from the breasts

  • decreased sexual desire or ability

• Some side effects can be serious. If you experience any of the following symptoms or those listed in the IMPORTANT WARNING or SPECIAL PRECAUTIONS section, call your doctor immediately or get emergency medical treatment:

  • fainting

  • falling

  • seizures

  • changes in vision

  • uncontrollable movements of your arms, legs, tongue, face, or lips

  • painful erection of the penis that lasts for hours

  • fever

  • muscle stiffness, pain, or weakness

  • excess sweating

  • fast or irregular heartbeat

  • confusion

  • unusual bleeding or bruising

  • sore throat, fever, chills, difficult or painful urination, or other signs of infection

  • hives

  • rash

  • blisters

  • tightening of the neck muscles or the throat

  • tongue sticking out

  • difficulty breathing or swallowing

• Quetiapine may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

• Quetiapine may cause cataracts. You will need to have eye exams to check for cataracts at the beginning of your treatment and every six months during your treatment. Talk to your doctor about the risks of taking quetiapine.

• If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include the following:

• drowsiness

• dizziness

• fainting

• fast heartbeat

Keep all appointments with your doctor and the laboratory. Your doctor may order certain lab tests to check your body's response to quetiapine.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug	Interaction
Moxifloxacin	Moxifloxacin The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Quetiapine.
Repaglinide	Repaglinide The therapeutic efficacy of Repaglinide can be decreased when used in combination with Quetiapine.
Insulin Glargine (rDNA origin) Injection	Insulin Glargine (rDNA origin) Injection The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Quetiapine.
Delavirdine	Delavirdine The serum concentration of Quetiapine can be increased when it is combined with Delavirdine.
Nevirapine	Nevirapine The metabolism of Quetiapine can be decreased when combined with Nevirapine.
Atorvastatin	Atorvastatin The metabolism of Quetiapine can be decreased when combined with Atorvastatin.
Dolasetron	Dolasetron The risk or severity of QTc prolongation can be increased when Dolasetron is combined with Quetiapine.
Anagrelide	Anagrelide The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Quetiapine.
Bisacodyl	Bisacodyl The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Quetiapine.
Candesartan	Candesartan Candesartan may increase the hypotensive activities of Quetiapine.
Cilostazol	Cilostazol The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Quetiapine.
Clopidogrel	Clopidogrel The metabolism of Quetiapine can be decreased when combined with Clopidogrel.
Diphenoxylate	Diphenoxylate The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Quetiapine.
Erythromycin and Sulfisoxazole	Erythromycin and Sulfisoxazole The metabolism of Quetiapine can be decreased when combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives)	Estrogen and Progestin (Oral Contraceptives) Conjugated estrogens may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Fenofibrate	Fenofibrate Fenofibrate may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Guanfacine	Guanfacine Guanfacine may increase the hypotensive activities of Quetiapine.
Magnesium Hydroxide	Magnesium Hydroxide Quetiapine may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Magnesium Oxide	Magnesium Oxide The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Quetiapine.
Methylergonovine	Methylergonovine The risk or severity of hypertension can be increased when Methylergometrine is combined with Quetiapine.
Miglitol	Miglitol The therapeutic efficacy of Miglitol can be decreased when used in combination with Quetiapine.
Mycophenolate	Mycophenolate Mycophenolic acid may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Naratriptan	Naratriptan The risk or severity of adverse effects can be increased when Naratriptan is combined with Quetiapine.
Olsalazine	Olsalazine Olsalazine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Paregoric	Paregoric The risk or severity of adverse effects can be increased when Morphine is combined with Quetiapine.
Penbutolol	Penbutolol Acebutolol may increase the hypotensive activities of Quetiapine.
Pentazocine	Pentazocine The risk or severity of adverse effects can be increased when Pentazocine is combined with Quetiapine.
Polyethylene glycol-electrolyte solution (PEG-ES)	Polyethylene glycol-electrolyte solution (PEG-ES) The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Quetiapine.
Potassium	Potassium Potassium may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone	Prednisone Prednisone may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Psyllium	Psyllium The therapeutic efficacy of Plantago seed can be decreased when used in combination with Quetiapine.
Ranitidine	Ranitidine The metabolism of Quetiapine can be decreased when combined with Ranitidine.
Reserpine	Reserpine Reserpine may increase the hypotensive activities of Quetiapine.
Rizatriptan	Rizatriptan Rizatriptan may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Sumatriptan	Sumatriptan Sumatriptan may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Tacrolimus	Tacrolimus The metabolism of Quetiapine can be decreased when combined with Tacrolimus.
Tizanidine	Tizanidine The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Quetiapine.
Triamcinolone	Triamcinolone The metabolism of Quetiapine can be increased when combined with Triamcinolone.
Zolmitriptan	Zolmitriptan The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Quetiapine.
Ampicillin Injection	Ampicillin Injection Ampicillin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Doxycycline Injection	Doxycycline Injection Doxycycline may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Famotidine Injection	Famotidine Injection The risk or severity of QTc prolongation can be increased when Famotidine is combined with Quetiapine.
Fluconazole Injection	Fluconazole Injection The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Quetiapine.
Foscarnet Injection	Foscarnet Injection The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Quetiapine.
Hydromorphone Injection	Hydromorphone Injection The risk or severity of adverse effects can be increased when Hydromorphone is combined with Quetiapine.
Levofloxacin Injection	Levofloxacin Injection The risk or severity of QTc prolongation can be increased when Levofloxacin is combined with Quetiapine.
Meperidine Injection	Meperidine Injection The risk or severity of adverse effects can be increased when Meperidine is combined with Quetiapine.
Metoclopramide Injection	Metoclopramide Injection The risk or severity of adverse effects can be increased when Metoclopramide is combined with Quetiapine.
Metronidazole Injection	Metronidazole Injection The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Quetiapine.
Morphine Injection	Morphine Injection The risk or severity of adverse effects can be increased when Morphine is combined with Quetiapine.
Pamidronate Injection	Pamidronate Injection Pamidronic acid may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Vancomycin Injection	Vancomycin Injection Quetiapine may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Altretamine	Altretamine Amphetamine may decrease the sedative and stimulatory activities of Quetiapine.
Cefuroxime	Cefuroxime Cefuroxime may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cyclosporine	Cyclosporine The metabolism of Quetiapine can be decreased when combined with Cyclosporine.
Ondansetron	Ondansetron The risk or severity of adverse effects can be increased when Ondansetron is combined with Quetiapine.
Granisetron	Granisetron The risk or severity of QTc prolongation can be increased when Granisetron is combined with Quetiapine.
Torsemide	Torsemide Quetiapine may increase the hypotensive activities of Torasemide.
Olanzapine	Olanzapine Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Alosetron	Alosetron Alosetron may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Dofetilide	Dofetilide The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Dofetilide.
Entacapone	Entacapone The therapeutic efficacy of Entacapone can be decreased when used in combination with Quetiapine.
Eprosartan	Eprosartan Quetiapine may increase the hypotensive activities of Eprosartan.
Hydroxychloroquine	Hydroxychloroquine The metabolism of Quetiapine can be decreased when combined with Hydroxychloroquine.
Meloxicam	Meloxicam Meloxicam may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Oxcarbazepine	Oxcarbazepine The metabolism of Quetiapine can be increased when combined with Oxcarbazepine.
Pantoprazole	Pantoprazole Pantoprazole may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Telmisartan	Telmisartan Telmisartan may increase the hypotensive activities of Quetiapine.
Temozolomide	Temozolomide Temozolomide may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Zaleplon	Zaleplon Zaleplon may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Anakinra	Anakinra The metabolism of Quetiapine can be increased when combined with Anakinra.
Desloratadine	Desloratadine Desloratadine may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Linezolid	Linezolid The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Quetiapine.
Rivastigmine	Rivastigmine The therapeutic efficacy of Quetiapine can be decreased when used in combination with Rivastigmine.
Trimipramine	Trimipramine Trimipramine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Etanercept Injection	Etanercept Injection The metabolism of Quetiapine can be increased when combined with Etanercept.
Glycopyrrolate	Glycopyrrolate The risk or severity of adverse effects can be increased when Quetiapine is combined with Glycopyrronium.
Modafinil	Modafinil The metabolism of Quetiapine can be increased when combined with Modafinil.
Perindopril	Perindopril Perindopril may increase the hypotensive activities of Quetiapine.
Tenofovir	Tenofovir Tenofovir may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Choline Magnesium Trisalicylate	Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Sirolimus	Sirolimus The metabolism of Sirolimus can be decreased when combined with Quetiapine.
Dutasteride	Dutasteride The metabolism of Quetiapine can be decreased when combined with Dutasteride.
Epinephrine Injection	Epinephrine Injection The therapeutic efficacy of Quetiapine can be decreased when used in combination with Epinephrine.
Eplerenone	Eplerenone Eplerenone may increase the hypotensive activities of Quetiapine.
Escitalopram	Escitalopram The risk or severity of serotonin syndrome can be increased when Escitalopram is combined with Quetiapine.
Olmesartan	Olmesartan Quetiapine may increase the hypotensive activities of Olmesartan.
Zonisamide	Zonisamide Zonisamide may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Adalimumab Injection	Adalimumab Injection The metabolism of Quetiapine can be increased when combined with Adalimumab.
Aripiprazole	Aripiprazole Quetiapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.
Atomoxetine	Atomoxetine The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Quetiapine.
Dexmethylphenidate	Dexmethylphenidate The risk or severity of adverse effects can be increased when Quetiapine is combined with Dexmethylphenidate.
Atazanavir	Atazanavir The serum concentration of Quetiapine can be increased when it is combined with Atazanavir.
Almotriptan	Almotriptan Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Eletriptan	Eletriptan Eletriptan may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Mefloquine	Mefloquine The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Quetiapine.
Polyethylene Glycol 3350	Polyethylene Glycol 3350 The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Quetiapine.
Rosuvastatin	Rosuvastatin The metabolism of Quetiapine can be decreased when combined with Rosuvastatin.
Vardenafil	Vardenafil The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Quetiapine.
Alfuzosin	Alfuzosin Alfuzosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Aprepitant	Aprepitant The metabolism of Quetiapine can be decreased when combined with Aprepitant.
Emtricitabine	Emtricitabine Emtricitabine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Memantine	Memantine The therapeutic efficacy of Quetiapine can be decreased when used in combination with Memantine.
Tegaserod	Tegaserod The metabolism of Quetiapine can be decreased when combined with Tegaserod.
Tadalafil	Tadalafil Tadalafil may increase the hypotensive activities of Quetiapine.
Frovatriptan	Frovatriptan The risk or severity of adverse effects can be increased when Frovatriptan is combined with Quetiapine.
Gemifloxacin	Gemifloxacin The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Quetiapine.
Progesterone	Progesterone The metabolism of Quetiapine can be decreased when combined with Progesterone.
Apomorphine Injection	Apomorphine Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Quetiapine.
Infliximab Injection	Infliximab Injection The metabolism of Quetiapine can be increased when combined with Infliximab.
Protriptyline	Protriptyline Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Rifaximin	Rifaximin The metabolism of Quetiapine can be increased when combined with Rifaximin.
Duloxetine	Duloxetine The risk or severity of orthostatic hypotension and syncope can be increased when Quetiapine is combined with Duloxetine.
Norethindrone	Norethindrone The metabolism of Quetiapine can be decreased when combined with Norethisterone.
Tinidazole	Tinidazole Tinidazole may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Trospium	Trospium Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Trospium.
Bosentan	Bosentan Bosentan may increase the hypotensive activities of Quetiapine.
Cefditoren	Cefditoren Cefdinir may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cinacalcet	Cinacalcet The metabolism of Quetiapine can be decreased when combined with Cinacalcet.
Cyanocobalamin Injection	Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Erlotinib	Erlotinib The metabolism of Quetiapine can be decreased when combined with Erlotinib.
Eszopiclone	Eszopiclone The risk or severity of CNS depression can be increased when Quetiapine is combined with Eszopiclone.
Ganciclovir	Ganciclovir Ganciclovir may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Insulin Aspart (rDNA Origin) Injection	Insulin Aspart (rDNA Origin) Injection The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Quetiapine.
Ribavirin	Ribavirin Ribavirin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Solifenacin	Solifenacin The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Quetiapine.
Valganciclovir	Valganciclovir Quetiapine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Voriconazole	Voriconazole The serum concentration of Quetiapine can be increased when it is combined with Voriconazole.
Adefovir	Adefovir Adefovir may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Dextroamphetamine	Dextroamphetamine Amphetamine may decrease the sedative and stimulatory activities of Quetiapine.
Peginterferon Alfa-2b (PEG-Intron)	Peginterferon Alfa-2b (PEG-Intron) The metabolism of Quetiapine can be decreased when combined with Peginterferon alfa-2b.
Pramlintide Injection	Pramlintide Injection The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Quetiapine.
Sodium Oxybate	Sodium Oxybate Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Exenatide Injection	Exenatide Injection The therapeutic efficacy of Exenatide can be decreased when used in combination with Quetiapine.
Ibandronate	Ibandronate The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Quetiapine.
Isocarboxazid	Isocarboxazid The risk or severity of adverse effects can be increased when Quetiapine is combined with Isocarboxazid.
Ramelteon	Ramelteon Ramelteon may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Darifenacin	Darifenacin The metabolism of Quetiapine can be decreased when combined with Darifenacin.
Fentanyl	Fentanyl The risk or severity of adverse effects can be increased when Quetiapine is combined with Fentanyl.
Pregabalin	Pregabalin The therapeutic efficacy of Quetiapine can be increased when used in combination with Pregabalin.
Phenylephrine	Phenylephrine The therapeutic efficacy of Phenylephrine can be decreased when used in combination with Quetiapine.
Tipranavir	Tipranavir The serum concentration of Quetiapine can be increased when it is combined with Tipranavir.
Felbamate	Felbamate The risk or severity of QTc prolongation can be increased when Felbamate is combined with Quetiapine.
Insulin Detemir (rDNA Origin) Injection	Insulin Detemir (rDNA Origin) Injection The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Quetiapine.
Ranolazine	Ranolazine The serum concentration of Quetiapine can be increased when it is combined with Ranolazine.
Abatacept Injection	Abatacept Injection The metabolism of Quetiapine can be increased when combined with Abatacept.
Rasagiline	Rasagiline Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Imatinib	Imatinib The risk or severity of QTc prolongation can be increased when Imatinib is combined with Quetiapine.
Sitagliptin	Sitagliptin The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Quetiapine.
Varenicline	Varenicline Quetiapine may decrease the excretion rate of Varenicline which could result in a higher serum level.
Gefitinib	Gefitinib The metabolism of Quetiapine can be decreased when combined with Gefitinib.
Albuterol	Albuterol The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Quetiapine.
Paliperidone	Paliperidone Quetiapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Paliperidone.
Bortezomib	Bortezomib The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Quetiapine.
Clofarabine Injection	Clofarabine Injection Clofarabine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Insulin Glulisine (rDNA origin) Injection	Insulin Glulisine (rDNA origin) Injection The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Quetiapine.
Lubiprostone	Lubiprostone Quetiapine may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Oxaliplatin Injection	Oxaliplatin Injection The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Quetiapine.
Posaconazole	Posaconazole The serum concentration of Quetiapine can be increased when it is combined with Posaconazole.
Primaquine	Primaquine The metabolism of Quetiapine can be decreased when combined with Primaquine.
Aliskiren	Aliskiren Quetiapine may increase the hypotensive activities of Aliskiren.
Darunavir	Darunavir The serum concentration of Darunavir can be increased when it is combined with Quetiapine.
Pemetrexed Injection	Pemetrexed Injection Quetiapine may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Dimenhydrinate	Dimenhydrinate The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Quetiapine.
Lisdexamfetamine	Lisdexamfetamine Lisdexamfetamine may decrease the sedative and stimulatory activities of Quetiapine.
Nabilone	Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Vorinostat	Vorinostat The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Quetiapine.
Sorafenib	Sorafenib The metabolism of Quetiapine can be decreased when combined with Sorafenib.
Sunitinib	Sunitinib The metabolism of Sunitinib can be decreased when combined with Quetiapine.
Dronabinol	Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Lapatinib	Lapatinib The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Lapatinib.
Levocetirizine	Levocetirizine The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Quetiapine.
Pegaptanib Injection	Pegaptanib Injection Quetiapine may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Dasatinib	Dasatinib The metabolism of Dasatinib can be decreased when combined with Quetiapine.
Mexiletine	Mexiletine The metabolism of Quetiapine can be decreased when combined with Mexiletine.
Armodafinil	Armodafinil The metabolism of Quetiapine can be increased when combined with Armodafinil.
Azacitidine Injection	Azacitidine Injection Azacitidine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Paclitaxel (with polyoxyethylated castor oil) Injection	Paclitaxel (with polyoxyethylated castor oil) Injection The therapeutic efficacy of Castor oil can be decreased when used in combination with Quetiapine.
Temsirolimus	Temsirolimus The metabolism of Temsirolimus can be decreased when combined with Quetiapine.
Lenalidomide	Lenalidomide Lenalidomide may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Nilotinib	Nilotinib The serum concentration of Quetiapine can be increased when it is combined with Nilotinib.
Toremifene	Toremifene The risk or severity of QTc prolongation can be increased when Toremifene is combined with Quetiapine.
Budesonide	Budesonide The metabolism of Quetiapine can be increased when combined with Budesonide.
Chloramphenicol Injection	Chloramphenicol Injection The metabolism of Quetiapine can be decreased when combined with Chloramphenicol.
Desmopressin	Desmopressin Desmopressin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Betaine	Betaine The therapeutic efficacy of Quetiapine can be decreased when used in combination with Glycine betaine.
OnabotulinumtoxinA Injection	OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Quetiapine is combined with Botulinum toxin type A.
RimabotulinumtoxinB Injection	RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Quetiapine is combined with Botulinum Toxin Type B.
Doripenem Injection	Doripenem Injection Quetiapine may decrease the excretion rate of Doripenem which could result in a higher serum level.
Arsenic Trioxide Injection	Arsenic Trioxide Injection The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Quetiapine.
Desvenlafaxine	Desvenlafaxine The risk or severity of adverse effects can be increased when Quetiapine is combined with Desvenlafaxine.
Cevimeline	Cevimeline Cevimeline may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Nebivolol	Nebivolol Quetiapine may increase the hypotensive activities of Nebivolol.
Tretinoin	Tretinoin The metabolism of Quetiapine can be decreased when combined with Tretinoin.
Flecainide	Flecainide The metabolism of Flecainide can be decreased when combined with Quetiapine.
Certolizumab Injection	Certolizumab Injection The metabolism of Quetiapine can be increased when combined with Certolizumab pegol.
Irinotecan Injection	Irinotecan Injection The metabolism of Quetiapine can be decreased when combined with Irinotecan.
Daptomycin Injection	Daptomycin Injection Daptomycin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Praziquantel	Praziquantel The metabolism of Quetiapine can be decreased when combined with Praziquantel.
Mitotane	Mitotane The metabolism of Quetiapine can be increased when combined with Mitotane.
Methylnaltrexone Injection	Methylnaltrexone Injection Quetiapine may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Rufinamide	Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Quetiapine.
Silodosin	Silodosin Quetiapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Silodosin.
Midazolam	Midazolam The risk or severity of adverse effects can be increased when Midazolam is combined with Quetiapine.
Naltrexone Injection	Naltrexone Injection The risk or severity of adverse effects can be increased when Naltrexone is combined with Quetiapine.
Dexrazoxane Injection	Dexrazoxane Injection Dexrazoxane may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Milnacipran	Milnacipran The risk or severity of adverse effects can be increased when Quetiapine is combined with Milnacipran.
Plerixafor Injection	Plerixafor Injection Quetiapine may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Sodium Phosphate	Sodium Phosphate The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Quetiapine.
Fesoterodine	Fesoterodine Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.
Degarelix Injection	Degarelix Injection The risk or severity of QTc prolongation can be increased when Degarelix is combined with Quetiapine.
Betaxolol	Betaxolol Betaxolol may increase the hypotensive activities of Quetiapine.
Iloperidone	Iloperidone Quetiapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Iloperidone.
Prasugrel	Prasugrel Quetiapine may decrease the excretion rate of Prasugrel which could result in a higher serum level.
Lacosamide	Lacosamide Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Everolimus	Everolimus The metabolism of Everolimus can be decreased when combined with Quetiapine.
Tolvaptan (low blood sodium)	Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.
Dronedarone	Dronedarone The metabolism of Dronedarone can be decreased when combined with Quetiapine.
AbobotulinumtoxinA Injection	AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Quetiapine is combined with Botulinum toxin type A.
Pralatrexate Injection	Pralatrexate Injection Quetiapine may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection	Palonosetron Injection Palonosetron may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Saxagliptin	Saxagliptin The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Quetiapine.
Telavancin Injection	Telavancin Injection The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Telavancin.
Romidepsin Injection	Romidepsin Injection The risk or severity of QTc prolongation can be increased when Romidepsin is combined with Quetiapine.
Tapentadol	Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Topotecan	Topotecan Topotecan may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Golimumab Injection	Golimumab Injection The metabolism of Quetiapine can be increased when combined with Golimumab.
Pazopanib	Pazopanib The risk or severity of QTc prolongation can be increased when Pazopanib is combined with Quetiapine.
Asenapine	Asenapine Quetiapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Asenapine.
Vigabatrin	Vigabatrin The risk or severity of adverse effects can be increased when Vigabatrin is combined with Quetiapine.
Levonorgestrel	Levonorgestrel The metabolism of Quetiapine can be decreased when combined with Levonorgestrel.
Oxymorphone	Oxymorphone The risk or severity of adverse effects can be increased when Quetiapine is combined with Oxymorphone.
Liraglutide Injection	Liraglutide Injection The therapeutic efficacy of Liraglutide can be decreased when used in combination with Quetiapine.
Tocilizumab Injection	Tocilizumab Injection The metabolism of Quetiapine can be increased when combined with Tocilizumab.
Dalfampridine	Dalfampridine Quetiapine may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
Eribulin Injection	Eribulin Injection The risk or severity of QTc prolongation can be increased when Eribulin is combined with Quetiapine.
IncobotulinumtoxinA Injection	IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Quetiapine is combined with Botulinum toxin type A.
Cabazitaxel Injection	Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Quetiapine.
Ceftaroline Injection	Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Lurasidone	Lurasidone Quetiapine may increase the hypotensive activities of Lurasidone.
Acetaminophen Injection	Acetaminophen Injection Acetaminophen may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Vilazodone	Vilazodone The metabolism of Vilazodone can be decreased when combined with Quetiapine.
Ipilimumab Injection	Ipilimumab Injection Quetiapine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection	Denileukin Diftitox Injection Aldesleukin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Terbutaline Injection	Terbutaline Injection The therapeutic efficacy of Quetiapine can be decreased when used in combination with Terbutaline.
Azilsartan	Azilsartan The risk or severity of adverse effects can be increased when Quetiapine is combined with Azilsartan medoxomil.
Roflumilast	Roflumilast Quetiapine may decrease the excretion rate of Roflumilast which could result in a higher serum level.
Linagliptin	Linagliptin The therapeutic efficacy of Linagliptin can be decreased when used in combination with Quetiapine.
Rilpivirine	Rilpivirine The metabolism of Rilpivirine can be decreased when combined with Quetiapine.
Cyclophosphamide Injection	Cyclophosphamide Injection The metabolism of Quetiapine can be decreased when combined with Cyclophosphamide.
Abiraterone	Abiraterone The metabolism of Quetiapine can be decreased when combined with Abiraterone.
Triptorelin Injection	Triptorelin Injection The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Quetiapine.
Rivaroxaban	Rivaroxaban Quetiapine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
Ruxolitinib	Ruxolitinib Quetiapine may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.
Vandetanib	Vandetanib The risk or severity of QTc prolongation can be increased when Vandetanib is combined with Quetiapine.
Clobazam	Clobazam The metabolism of Quetiapine can be decreased when combined with Clobazam.
Vemurafenib	Vemurafenib The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Quetiapine.
Ivacaftor	Ivacaftor The metabolism of Ivacaftor can be decreased when combined with Quetiapine.
Deferiprone	Deferiprone Quetiapine may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Axitinib	Axitinib The metabolism of Axitinib can be decreased when combined with Quetiapine.
Crizotinib	Crizotinib The metabolism of Quetiapine can be decreased when combined with Crizotinib.
Cabergoline	Cabergoline Cabergoline may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Naloxone Injection	Naloxone Injection The serum concentration of Quetiapine can be increased when it is combined with Naloxone.
Ambrisentan	Ambrisentan Quetiapine may increase the hypotensive activities of Ambrisentan.
Fondaparinux Injection	Fondaparinux Injection Fondaparinux may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Ezogabine	Ezogabine Tiagabine may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Iloprost	Iloprost The risk or severity of adverse effects can be increased when Iloprost is combined with Quetiapine.
Enzalutamide	Enzalutamide The metabolism of Quetiapine can be increased when combined with Enzalutamide.
Mirabegron	Mirabegron The risk or severity of urinary retention can be increased when Quetiapine is combined with Mirabegron.
Linaclotide	Linaclotide The therapeutic efficacy of Linaclotide can be decreased when used in combination with Quetiapine.
Lorcaserin	Lorcaserin The therapeutic efficacy of Mecasermin can be decreased when used in combination with Quetiapine.
Teduglutide Injection	Teduglutide Injection Quetiapine may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Bedaquiline	Bedaquiline The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Bedaquiline.
Alogliptin	Alogliptin The therapeutic efficacy of Alogliptin can be decreased when used in combination with Quetiapine.
Ponatinib	Ponatinib The metabolism of Ponatinib can be decreased when combined with Quetiapine.
Pomalidomide	Pomalidomide Pomalidomide may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Ado-trastuzumab Emtansine Injection	Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Quetiapine.
Apixaban	Apixaban The metabolism of Apixaban can be decreased when combined with Quetiapine.
Canagliflozin	Canagliflozin The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Quetiapine.
Methazolamide	Methazolamide Methazolamide may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.
Dabrafenib	Dabrafenib The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Quetiapine.
Ospemifene	Ospemifene The metabolism of Quetiapine can be decreased when combined with Ospemifene.
Trametinib	Trametinib Quetiapine may decrease the excretion rate of Trametinib which could result in a higher serum level.
Levomilnacipran	Levomilnacipran The risk or severity of adverse effects can be increased when Quetiapine is combined with Levomilnacipran.
Ertapenem Injection	Ertapenem Injection Ertapenem may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Vortioxetine	Vortioxetine The risk or severity of adverse effects can be increased when Quetiapine is combined with Vortioxetine.
Perampanel	Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Ibrutinib	Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Quetiapine.
Avanafil	Avanafil The risk or severity of hypotension, dyspepsia, and headache can be increased when Avanafil is combined with Quetiapine.
Ketorolac Injection	Ketorolac Injection Ketorolac may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Obinutuzumab Injection	Obinutuzumab Injection The risk or severity of adverse effects can be increased when Quetiapine is combined with Obinutuzumab.
Sofosbuvir	Sofosbuvir Quetiapine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin	Dapagliflozin The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Quetiapine.
Apremilast	Apremilast The metabolism of Quetiapine can be increased when combined with Apremilast.
Droxidopa	Droxidopa The therapeutic efficacy of Droxidopa can be decreased when used in combination with Quetiapine.
Ceritinib	Ceritinib The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Ceritinib.
Siltuximab Injection	Siltuximab Injection The metabolism of Quetiapine can be increased when combined with Siltuximab.
Albiglutide Injection	Albiglutide Injection The therapeutic efficacy of Albiglutide can be decreased when used in combination with Quetiapine.
Eslicarbazepine	Eslicarbazepine Eslicarbazepine may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Testosterone Injection	Testosterone Injection Testosterone may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Oritavancin Injection	Oritavancin Injection The metabolism of Quetiapine can be decreased when combined with Oritavancin.
Empagliflozin	Empagliflozin The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Quetiapine.
Hydrocodone	Hydrocodone Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Suvorexant	Suvorexant Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Dulaglutide Injection	Dulaglutide Injection The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Quetiapine.
Edoxaban	Edoxaban Quetiapine may decrease the excretion rate of Edoxaban which could result in a higher serum level.
Olaparib	Olaparib The metabolism of Olaparib can be decreased when combined with Quetiapine.
Methamphetamine	Methamphetamine Metamfetamine may decrease the sedative and stimulatory activities of Quetiapine.
Tasimelteon	Tasimelteon Tasimelteon may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Riociguat	Riociguat Quetiapine may increase the hypotensive activities of Riociguat.
Secukinumab Injection	Secukinumab Injection The metabolism of Quetiapine can be increased when combined with Secukinumab.
Risperidone Injection	Risperidone Injection Quetiapine may increase the hypotensive activities of Risperidone.
Insulin Human Inhalation	Insulin Human Inhalation The therapeutic efficacy of Insulin human can be decreased when used in combination with Quetiapine.
Lenvatinib	Lenvatinib The metabolism of Quetiapine can be decreased when combined with Lenvatinib.
Naloxegol	Naloxegol The metabolism of Quetiapine can be decreased when combined with Naloxegol.
Panobinostat	Panobinostat The metabolism of Quetiapine can be decreased when combined with Panobinostat.
Dinutuximab Injection	Dinutuximab Injection The risk or severity of adverse effects can be increased when Quetiapine is combined with Dinutuximab.
Haloperidol Injection	Haloperidol Injection The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Quetiapine.
Ivabradine	Ivabradine Quetiapine may increase the QTc-prolonging activities of Ivabradine.
Amiloride	Amiloride Amiloride may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.
Macitentan	Macitentan Quetiapine may increase the hypotensive activities of Macitentan.
Flibanserin	Flibanserin Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Rolapitant	Rolapitant The metabolism of Quetiapine can be decreased when combined with Rolapitant.
Daclatasvir	Daclatasvir The metabolism of Daclatasvir can be decreased when combined with Quetiapine.
Brexpiprazole	Brexpiprazole Brexpiprazole may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Ziprasidone Injection	Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Quetiapine.
Cariprazine	Cariprazine The risk or severity of adverse effects can be increased when Quetiapine is combined with Cariprazine.
Penicillin G Procaine Injection	Penicillin G Procaine Injection Quetiapine may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Eluxadoline	Eluxadoline The risk or severity of constipation can be increased when Quetiapine is combined with Eluxadoline.
Insulin Degludec (rDNA Origin) Injection	Insulin Degludec (rDNA Origin) Injection The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Quetiapine.
Trabectedin Injection	Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Quetiapine.
Ixazomib	Ixazomib Quetiapine may decrease the excretion rate of Ixazomib which could result in a higher serum level.
Lesinurad	Lesinurad Quetiapine may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection	Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Dexamethasone Injection	Dexamethasone Injection The metabolism of Quetiapine can be increased when combined with Dexamethasone.
Brivaracetam Injection	Brivaracetam Injection Brivaracetam may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Cobicistat	Cobicistat The serum concentration of Quetiapine can be increased when it is combined with Cobicistat.
Midodrine	Midodrine The therapeutic efficacy of Midodrine can be decreased when used in combination with Quetiapine.
Selexipag	Selexipag Quetiapine may increase the hypotensive activities of Selexipag.
Pimavanserin	Pimavanserin The risk or severity of adverse effects can be increased when Quetiapine is combined with Pimavanserin.
Diphenhydramine Injection	Diphenhydramine Injection The metabolism of Quetiapine can be decreased when combined with Diphenhydramine.
Furosemide Injection	Furosemide Injection Furosemide may increase the hypotensive activities of Quetiapine.
Rucaparib	Rucaparib The metabolism of Quetiapine can be decreased when combined with Rucaparib.
Lixisenatide Injection	Lixisenatide Injection The therapeutic efficacy of Lixisenatide can be decreased when used in combination with Quetiapine.
Ribociclib	Ribociclib The serum concentration of Quetiapine can be increased when it is combined with Ribociclib.
Doxepin (Insomnia)	Doxepin (Insomnia) Doxepin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Plecanatide	Plecanatide The therapeutic efficacy of Plecanatide can be decreased when used in combination with Quetiapine.
Deutetrabenazine	Deutetrabenazine The risk or severity of adverse effects can be increased when Quetiapine is combined with Deutetrabenazine.
Valbenazine	Valbenazine Quetiapine may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Deflazacort	Deflazacort The metabolism of Quetiapine can be increased when combined with Deflazacort.
Safinamide	Safinamide The metabolism of Quetiapine can be decreased when combined with Safinamide.
Naldemedine	Naldemedine Quetiapine may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Midostaurin	Midostaurin The serum concentration of Quetiapine can be increased when it is combined with Midostaurin.
Enasidenib	Enasidenib The metabolism of Quetiapine can be decreased when combined with Enasidenib.
Benznidazole	Benznidazole Quetiapine may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Copanlisib Injection	Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Quetiapine.
Delafloxacin	Delafloxacin The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Quetiapine.
Acalabrutinib	Acalabrutinib The metabolism of Quetiapine can be decreased when combined with Acalabrutinib.
Letermovir	Letermovir The metabolism of Quetiapine can be decreased when combined with Letermovir.
Semaglutide Injection	Semaglutide Injection The therapeutic efficacy of Semaglutide can be decreased when used in combination with Quetiapine.
Tetrabenazine	Tetrabenazine The risk or severity of adverse effects can be increased when Quetiapine is combined with Tetrabenazine.
Ertugliflozin	Ertugliflozin The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Quetiapine.
Buprenorphine Injection	Buprenorphine Injection Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Apalutamide	Apalutamide The metabolism of Quetiapine can be increased when combined with Apalutamide.
Fostamatinib	Fostamatinib The risk or severity of hypotension, dyspepsia, and headache can be increased when Fostamatinib is combined with Quetiapine.
Baricitinib	Baricitinib Quetiapine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Lofexidine	Lofexidine The therapeutic efficacy of Quetiapine can be increased when used in combination with Lofexidine.
Plazomicin Injection	Plazomicin Injection Quetiapine may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Eliglustat	Eliglustat The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Eliglustat.
Encorafenib	Encorafenib The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Encorafenib.
Ivosidenib	Ivosidenib The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Ivosidenib.
Elagolix	Elagolix The metabolism of Elagolix can be decreased when combined with Quetiapine.
Doravirine	Doravirine The metabolism of Doravirine can be decreased when combined with Quetiapine.
Tafenoquine	Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Quetiapine.
Cannabidiol	Cannabidiol The risk or severity of adverse effects can be increased when Cannabidiol is combined with Quetiapine.
Dacomitinib	Dacomitinib The metabolism of Quetiapine can be decreased when combined with Dacomitinib.
Stiripentol	Stiripentol The serum concentration of Quetiapine can be increased when it is combined with Stiripentol.
Gilteritinib	Gilteritinib The therapeutic efficacy of Quetiapine can be decreased when used in combination with Gilteritinib.
Glasdegib	Glasdegib The risk or severity of QTc prolongation can be increased when Glasdegib is combined with Quetiapine.
Lorlatinib	Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Quetiapine.
Paclitaxel (with albumin) Injection	Paclitaxel (with albumin) Injection The metabolism of Quetiapine can be decreased when combined with Paclitaxel.
Rifamycin	Rifamycin The metabolism of Quetiapine can be increased when combined with Rifamycin.
Prucalopride	Prucalopride Quetiapine may decrease the excretion rate of Prucalopride which could result in a higher serum level.
Magnesium Citrate	Magnesium Citrate The therapeutic efficacy of Magnesium citrate can be decreased when used in combination with Quetiapine.
Emapalumab-lzsg Injection	Emapalumab-lzsg Injection The metabolism of Quetiapine can be increased when combined with Emapalumab.
Siponimod	Siponimod The risk or severity of hypertension can be increased when Quetiapine is combined with Siponimod.
Acyclovir Ophthalmic	Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Brexanolone Injection	Brexanolone Injection The risk or severity of adverse effects can be increased when Quetiapine is combined with Brexanolone.
Solriamfetol	Solriamfetol The risk or severity of hypertension can be increased when Solriamfetol is combined with Quetiapine.
Triclabendazole	Triclabendazole The metabolism of Quetiapine can be decreased when combined with Triclabendazole.
Entrectinib	Entrectinib The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Entrectinib.
Istradefylline	Istradefylline The metabolism of Istradefylline can be decreased when combined with Quetiapine.
Pitolisant	Pitolisant The therapeutic efficacy of Pitolisant can be decreased when used in combination with Quetiapine.
Fedratinib	Fedratinib The metabolism of Quetiapine can be decreased when combined with Fedratinib.
Lefamulin	Lefamulin Lefamulin may increase the QTc-prolonging activities of Quetiapine.
Phenytoin Injection	Phenytoin Injection The metabolism of Quetiapine can be increased when combined with Phenytoin.
Fosphenytoin Injection	Fosphenytoin Injection The metabolism of Quetiapine can be increased when combined with Fosphenytoin.
Lumateperone	Lumateperone The risk or severity of adverse effects can be increased when Quetiapine is combined with Lumateperone.
Lasmiditan	Lasmiditan The risk or severity of serotonin syndrome can be increased when Quetiapine is combined with Lasmiditan.
Cenobamate	Cenobamate The serum concentration of Quetiapine can be decreased when it is combined with Cenobamate.
Selumetinib	Selumetinib The metabolism of Selumetinib can be decreased when combined with Quetiapine.
Tucatinib	Tucatinib The metabolism of Tucatinib can be decreased when combined with Quetiapine.
Selpercatinib	Selpercatinib The risk or severity of hypertension can be increased when Quetiapine is combined with Selpercatinib.
Lemborexant	Lemborexant Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Lemborexant.
Fenfluramine	Fenfluramine The risk or severity of serotonin syndrome can be increased when Fenfluramine is combined with Quetiapine.
Fostemsavir	Fostemsavir The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Quetiapine.
Octreotide	Octreotide The risk or severity of QTc prolongation can be increased when Octreotide is combined with Quetiapine.
Pralsetinib	Pralsetinib The metabolism of Quetiapine can be decreased when combined with Pralsetinib.
Opicapone	Opicapone The therapeutic efficacy of Opicapone can be decreased when used in combination with Quetiapine.
Satralizumab-mwge Injection	Satralizumab-mwge Injection The serum concentration of Quetiapine can be decreased when it is combined with Satralizumab.
Naxitamab-gqgk Injection	Naxitamab-gqgk Injection The risk or severity of hypertension can be increased when Quetiapine is combined with Naxitamab.
Relugolix	Relugolix The risk or severity of QTc prolongation can be increased when Relugolix is combined with Quetiapine.
Progestin-Only (drospirenone) Oral Contraceptives	Progestin-Only (drospirenone) Oral Contraceptives Drospirenone may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.
Viloxazine	Viloxazine The risk or severity of adverse effects can be increased when Quetiapine is combined with Viloxazine.
Tobramycin Injection	Tobramycin Injection Tobramycin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Theophylline	Theophylline The metabolism of Quetiapine can be decreased when combined with Theophylline.
Fenoprofen	Fenoprofen Fenoprofen may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Indomethacin	Indomethacin Indomethacin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Mefenamic Acid	Mefenamic Acid Mefenamic acid may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Naproxen	Naproxen Naproxen may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Tolmetin	Tolmetin Tolmetin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Sulindac	Sulindac Sulindac may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Trazodone	Trazodone The risk or severity of QTc prolongation can be increased when Trazodone is combined with Quetiapine.
Isotretinoin	Isotretinoin Isotretinoin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Sucralfate	Sucralfate Sucralfate may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Hydroxyurea	Hydroxyurea The metabolism of Quetiapine can be decreased when combined with Hydroxyurea.
Floxuridine	Floxuridine Floxuridine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Phenobarbital	Phenobarbital The metabolism of Quetiapine can be increased when combined with Phenobarbital.
Metaxalone	Metaxalone Metaxalone may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Methotrexate Injection	Methotrexate Injection Methotrexate may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Levorphanol	Levorphanol The risk or severity of adverse effects can be increased when Levorphanol is combined with Quetiapine.
Primidone	Primidone The metabolism of Quetiapine can be increased when combined with Primidone.
Methsuximide	Methsuximide The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Quetiapine.
Diethylpropion	Diethylpropion Diethylpropion may decrease the sedative and stimulatory activities of Quetiapine.
Chlorpromazine	Chlorpromazine Chlorpromazine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Diazepam	Diazepam The risk or severity of adverse effects can be increased when Diazepam is combined with Quetiapine.
Oxazepam	Oxazepam The risk or severity of adverse effects can be increased when Oxazepam is combined with Quetiapine.
Flurazepam	Flurazepam The risk or severity of adverse effects can be increased when Flurazepam is combined with Quetiapine.
Clorazepate	Clorazepate The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Quetiapine.
Lorazepam	Lorazepam The serum concentration of Quetiapine can be increased when it is combined with Lorazepam.
Phenoxybenzamine	Phenoxybenzamine Phenoxybenzamine may increase the hypotensive activities of Quetiapine.
Carmustine	Carmustine Carmustine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Amantadine	Amantadine The risk or severity of QTc prolongation can be increased when Amantadine is combined with Quetiapine.
Codeine	Codeine The risk or severity of adverse effects can be increased when Codeine is combined with Quetiapine.
Meprobamate	Meprobamate The risk or severity of adverse effects can be increased when Meprobamate is combined with Quetiapine.
Chlordiazepoxide	Chlordiazepoxide The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Quetiapine.
Bromocriptine	Bromocriptine Bromocriptine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Metaproterenol	Metaproterenol The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Quetiapine.
Tranylcypromine	Tranylcypromine The metabolism of Quetiapine can be decreased when combined with Tranylcypromine.
Phenelzine	Phenelzine The risk or severity of adverse effects can be increased when Phenelzine is combined with Quetiapine.
Procarbazine	Procarbazine The risk or severity of adverse effects can be increased when Procarbazine is combined with Quetiapine.
Ergoloid Mesylates	Ergoloid Mesylates Ergoloid mesylate may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Tetracycline	Tetracycline Tetracycline may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Minocycline	Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Prochlorperazine	Prochlorperazine The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Quetiapine.
Thioridazine	Thioridazine The serum concentration of Quetiapine can be decreased when it is combined with Thioridazine.
Trifluoperazine	Trifluoperazine Trifluoperazine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Bleomycin	Bleomycin Bleomycin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Dapsone	Dapsone The metabolism of Quetiapine can be decreased when combined with Dapsone.
Sulfadiazine	Sulfadiazine The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Quetiapine.
Oxycodone	Oxycodone The risk or severity of adverse effects can be increased when Oxycodone is combined with Quetiapine.
Methadone	Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Quetiapine.
Oxybutynin	Oxybutynin The metabolism of Quetiapine can be decreased when combined with Oxybutynin.
Benztropine	Benztropine The risk or severity of adverse effects can be increased when Quetiapine is combined with Benzatropine.
Maprotiline	Maprotiline The risk or severity of adverse effects can be increased when Maprotiline is combined with Quetiapine.
Ibuprofen	Ibuprofen Ibuprofen may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Trihexyphenidyl	Trihexyphenidyl The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Quetiapine.
Orphenadrine	Orphenadrine Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Perphenazine	Perphenazine The risk or severity of adverse effects can be increased when Perphenazine is combined with Quetiapine.
Azathioprine	Azathioprine Azathioprine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Fluphenazine	Fluphenazine The risk or severity of adverse effects can be increased when Fluphenazine is combined with Quetiapine.
Phentermine	Phentermine Phentermine may decrease the sedative and stimulatory activities of Quetiapine.
Methylphenidate	Methylphenidate The risk or severity of adverse effects can be increased when Quetiapine is combined with Methylphenidate.
Amoxapine	Amoxapine Amoxapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Sulfasalazine	Sulfasalazine Sulfasalazine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Hydrocortisone	Hydrocortisone The metabolism of Quetiapine can be decreased when combined with Hydrocortisone.
Doxorubicin	Doxorubicin The metabolism of Quetiapine can be decreased when combined with Doxorubicin.
Mechlorethamine	Mechlorethamine The therapeutic efficacy of Quetiapine can be decreased when used in combination with Mechlorethamine.
Pyridostigmine	Pyridostigmine The therapeutic efficacy of Quetiapine can be decreased when used in combination with Pyridostigmine.
Phenazopyridine	Phenazopyridine Phenazopyridine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Carbamazepine	Carbamazepine The serum concentration of the active metabolites of Carbamazepine can be increased when Carbamazepine is used in combination with Quetiapine.
Molindone	Molindone The risk or severity of adverse effects can be increased when Quetiapine is combined with Molindone.
Methyldopa	Methyldopa Methyldopa may increase the hypotensive activities of Quetiapine.
Clonidine	Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Quetiapine.
Prazosin	Prazosin Prazosin may increase the hypotensive activities of Quetiapine.
Hydralazine	Hydralazine Quetiapine may increase the hypotensive activities of Hydralazine.
Cimetidine	Cimetidine The metabolism of Quetiapine can be decreased when combined with Cimetidine.
Gentamicin Injection	Gentamicin Injection Gentamicin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Warfarin	Warfarin Quetiapine may decrease the excretion rate of Warfarin which could result in a higher serum level.
Clonazepam	Clonazepam Clonazepam may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Loperamide	Loperamide The serum concentration of Quetiapine can be increased when it is combined with Loperamide.
Promethazine	Promethazine Promethazine may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Meclofenamate	Meclofenamate Meclofenamic acid may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Daunorubicin	Daunorubicin The metabolism of Quetiapine can be increased when combined with Daunorubicin.
Nitrofurantoin	Nitrofurantoin Nitrofurantoin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Digoxin	Digoxin Digoxin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Loxapine	Loxapine The risk or severity of adverse effects can be increased when Loxapine is combined with Quetiapine.
Chloroquine	Chloroquine The metabolism of Quetiapine can be decreased when combined with Chloroquine.
Quinine	Quinine The metabolism of Quetiapine can be decreased when combined with Quinine.
Ethosuximide	Ethosuximide The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Quetiapine.
Triamterene	Triamterene Triamterene may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Lactulose	Lactulose The therapeutic efficacy of Lactulose can be decreased when used in combination with Quetiapine.
Chlorothiazide	Chlorothiazide Quetiapine may increase the hypotensive activities of Chlorothiazide.
Chlorthalidone	Chlorthalidone Quetiapine may increase the hypotensive activities of Chlorthalidone.
Metolazone	Metolazone Metolazone may increase the hypotensive activities of Quetiapine.
Isosorbide	Isosorbide Isosorbide may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.
Clindamycin Injection	Clindamycin Injection The metabolism of Quetiapine can be decreased when combined with Clindamycin.
Secobarbital	Secobarbital Secobarbital may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Desipramine	Desipramine The metabolism of Quetiapine can be decreased when combined with Desipramine.
Amitriptyline	Amitriptyline Amitriptyline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Imipramine	Imipramine Imipramine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Probenecid	Probenecid Probenecid may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Quinidine	Quinidine Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Procainamide	Procainamide The metabolism of Procainamide can be decreased when combined with Quetiapine.
Isoniazid	Isoniazid The risk or severity of serotonin syndrome can be increased when Isoniazid is combined with Quetiapine.
Pyrazinamide	Pyrazinamide Pyrazinamide may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Rifampin	Rifampin The metabolism of Quetiapine can be increased when combined with Rifampicin.
Disopyramide	Disopyramide The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Disopyramide.
Valproic Acid	Valproic Acid The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Quetiapine.
Tamoxifen	Tamoxifen The metabolism of Quetiapine can be decreased when combined with Tamoxifen.
Butabarbital	Butabarbital The risk or severity of adverse effects can be increased when Butabarbital is combined with Quetiapine.
Liothyronine	Liothyronine Liothyronine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Methimazole	Methimazole The serum concentration of Quetiapine can be increased when it is combined with Methimazole.
Chlorpropamide	Chlorpropamide The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Quetiapine.
Glucagon Injection	Glucagon Injection Quetiapine may increase the gastrointestinal motility reducing activities of Glucagon.
Tolbutamide	Tolbutamide The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Quetiapine.
Tolazamide	Tolazamide The therapeutic efficacy of Tolazamide can be decreased when used in combination with Quetiapine.
Dextromethorphan	Dextromethorphan Dextromethorphan may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Cyclobenzaprine	Cyclobenzaprine The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Quetiapine.
Niacin	Niacin The metabolism of Quetiapine can be decreased when combined with Niacin.
Baclofen	Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Quetiapine.
Doxylamine	Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Cyproheptadine	Cyproheptadine The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Quetiapine.
Clemastine	Clemastine The risk or severity of QTc prolongation can be increased when Clemastine is combined with Quetiapine.
Chlorpheniramine	Chlorpheniramine The metabolism of Quetiapine can be decreased when combined with Chlorpheniramine.
Brompheniramine	Brompheniramine The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Quetiapine.
Meclizine	Meclizine The risk or severity of adverse effects can be increased when Meclizine is combined with Quetiapine.
Ethambutol	Ethambutol Ethambutol may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Methyclothiazide	Methyclothiazide Methyclothiazide may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.
Hydrochlorothiazide	Hydrochlorothiazide Hydrochlorothiazide may increase the hypotensive activities of Quetiapine.
Dantrolene	Dantrolene Dantrolene may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Chlorzoxazone	Chlorzoxazone Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Carisoprodol	Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Quetiapine.
Methocarbamol	Methocarbamol The risk or severity of adverse effects can be increased when Methocarbamol is combined with Quetiapine.
Pyridoxine	Pyridoxine Pyridoxine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Folic Acid	Folic Acid Folic acid may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Disulfiram	Disulfiram The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Quetiapine.
Propranolol (Cardiovascular)	Propranolol (Cardiovascular) Propranolol may increase the hypotensive activities of Quetiapine.
Minoxidil	Minoxidil Quetiapine may increase the hypotensive activities of Minoxidil.
Pseudoephedrine	Pseudoephedrine Pseudoephedrine may decrease the sedative and stimulatory activities of Quetiapine.
Nortriptyline	Nortriptyline Nortriptyline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Spironolactone	Spironolactone Spironolactone may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.
Amphotericin B Injection	Amphotericin B Injection Amphotericin B may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Phytonadione	Phytonadione Phylloquinone may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Amikacin Injection	Amikacin Injection Amikacin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Nadolol	Nadolol Nadolol may increase the hypotensive activities of Quetiapine.
Butorphanol Injection	Butorphanol Injection The risk or severity of adverse effects can be increased when Butorphanol is combined with Quetiapine.
Nalbuphine Injection	Nalbuphine Injection The risk or severity of adverse effects can be increased when Nalbuphine is combined with Quetiapine.
Allopurinol	Allopurinol Allopurinol may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Oxytocin Injection	Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Quetiapine.
Trimethobenzamide	Trimethobenzamide Trimethobenzamide may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Flavoxate	Flavoxate Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.
Papaverine	Papaverine The risk or severity of QTc prolongation can be increased when Papaverine is combined with Quetiapine.
Fluorouracil Injection	Fluorouracil Injection The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Quetiapine.
Colchicine	Colchicine Quetiapine may decrease the excretion rate of Colchicine which could result in a higher serum level.
Cefaclor	Cefaclor Cefaclor may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cefadroxil	Cefadroxil Cefadroxil may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cefazolin Injection	Cefazolin Injection Cefazolin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cephalexin	Cephalexin Cephalexin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cefoxitin Injection	Cefoxitin Injection Cefoxitin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Dacarbazine	Dacarbazine Dacarbazine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Acetazolamide	Acetazolamide Acetazolamide may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.
Cefotaxime Injection	Cefotaxime Injection Cefotaxime may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Calcitonin Salmon Injection	Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Ketoconazole	Ketoconazole The serum concentration of Quetiapine can be increased when it is combined with Ketoconazole.
Pyrantel	Pyrantel The risk or severity of adverse effects can be increased when Quetiapine is combined with Pyrantel.
Thiotepa Injection	Thiotepa Injection The therapeutic efficacy of Thiotepa can be decreased when used in combination with Quetiapine.
Vincristine Injection	Vincristine Injection The metabolism of Quetiapine can be decreased when combined with Vincristine.
Captopril	Captopril Captopril may increase the hypotensive activities of Quetiapine.
Dipyridamole	Dipyridamole The risk or severity of hypotension, dyspepsia, and headache can be increased when Dipyridamole is combined with Quetiapine.
Isoxsuprine	Isoxsuprine The therapeutic efficacy of Isoxsuprine can be decreased when used in combination with Quetiapine.
Vinblastine	Vinblastine The metabolism of Quetiapine can be decreased when combined with Vinblastine.
Ethacrynic Acid	Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Colistimethate Injection	Colistimethate Injection Colistimethate may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Metoprolol	Metoprolol Metoprolol may increase the hypotensive activities of Quetiapine.
Hydroxyzine	Hydroxyzine The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Quetiapine.
Thiothixene	Thiothixene The risk or severity of adverse effects can be increased when Quetiapine is combined with Thiothixene.
Aspirin	Aspirin Acetylsalicylic acid may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Salsalate	Salsalate Salsalate may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Alprazolam	Alprazolam The risk or severity of adverse effects can be increased when Alprazolam is combined with Quetiapine.
Temazepam	Temazepam The risk or severity of adverse effects can be increased when Temazepam is combined with Quetiapine.
Triazolam	Triazolam The risk or severity of adverse effects can be increased when Triazolam is combined with Quetiapine.
Dicyclomine	Dicyclomine Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Hyoscyamine	Hyoscyamine The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Quetiapine.
Propantheline	Propantheline Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Propantheline.
Trimethoprim	Trimethoprim Trimethoprim may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Diltiazem	Diltiazem Diltiazem may increase the hypotensive activities of Quetiapine.
Nifedipine	Nifedipine The metabolism of Quetiapine can be decreased when combined with Nifedipine.
Timolol	Timolol Timolol may increase the hypotensive activities of Quetiapine.
Verapamil	Verapamil Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Atenolol	Atenolol Atenolol may increase the hypotensive activities of Quetiapine.
Pindolol	Pindolol Pindolol may increase the hypotensive activities of Quetiapine.
Cisplatin Injection	Cisplatin Injection Cisplatin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Diflunisal	Diflunisal Diflunisal may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Piroxicam	Piroxicam Piroxicam may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Bumetanide	Bumetanide Bumetanide may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.
Etoposide	Etoposide The metabolism of Quetiapine can be decreased when combined with Etoposide.
Glyburide	Glyburide The therapeutic efficacy of Quetiapine can be decreased when used in combination with Glyburide.
Glipizide	Glipizide The therapeutic efficacy of Quetiapine can be decreased when used in combination with Glipizide.
Indapamide	Indapamide Indapamide may increase the hypotensive activities of Quetiapine.
Amoxicillin	Amoxicillin Amoxicillin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Oxacillin Injection	Oxacillin Injection Oxacillin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Pentoxifylline	Pentoxifylline The risk or severity of hypotension, dyspepsia, and headache can be increased when Pentoxifylline is combined with Quetiapine.
Pentamidine Injection	Pentamidine Injection The risk or severity of QTc prolongation can be increased when Pentamidine is combined with Quetiapine.
Ceftriaxone Injection	Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Labetalol	Labetalol Labetalol may increase the hypotensive activities of Quetiapine.
Auranofin	Auranofin Auranofin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Leuprolide Injection	Leuprolide Injection The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Quetiapine.
Gemfibrozil	Gemfibrozil Quetiapine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.
Guanabenz	Guanabenz Quetiapine may increase the hypotensive activities of Guanabenz.
Dipivefrin Ophthalmic	Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Ceftazidime Injection	Ceftazidime Injection Ceftazidime may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Ketoprofen	Ketoprofen Ketoprofen may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cefotetan Injection	Cefotetan Injection Cefotetan may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Pimozide	Pimozide The metabolism of Quetiapine can be decreased when combined with Pimozide.
Enalapril	Enalapril Enalapril may increase the hypotensive activities of Quetiapine.
Flurbiprofen	Flurbiprofen Flurbiprofen may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Amiodarone	Amiodarone The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Quetiapine.
Aztreonam Injection	Aztreonam Injection Aztreonam may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Buspirone	Buspirone The risk or severity of serotonin syndrome can be increased when Buspirone is combined with Quetiapine.
Lovastatin	Lovastatin The metabolism of Quetiapine can be decreased when combined with Lovastatin.
Ciprofloxacin	Ciprofloxacin The metabolism of Quetiapine can be decreased when combined with Ciprofloxacin.
Mesalamine	Mesalamine Mesalazine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Diclofenac	Diclofenac Diclofenac may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Fluoxetine	Fluoxetine The serum concentration of Quetiapine can be increased when it is combined with Fluoxetine.
Nimodipine	Nimodipine Nimodipine may increase the hypotensive activities of Quetiapine.
Clozapine	Clozapine Clozapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Estazolam	Estazolam The risk or severity of adverse effects can be increased when Estazolam is combined with Quetiapine.
Idarubicin	Idarubicin The metabolism of Quetiapine can be decreased when combined with Idarubicin.
Ofloxacin	Ofloxacin The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Quetiapine.
Didanosine	Didanosine Didanosine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Pentostatin Injection	Pentostatin Injection Pentostatin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Clarithromycin	Clarithromycin The serum concentration of Quetiapine can be increased when it is combined with Clarithromycin.
Benazepril	Benazepril Quetiapine may increase the hypotensive activities of Benazepril.
Etodolac	Etodolac Etodolac may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Felodipine	Felodipine Felodipine may increase the hypotensive activities of Quetiapine.
Fosinopril	Fosinopril Fosinopril may increase the hypotensive activities of Quetiapine.
Nabumetone	Nabumetone Nabumetone may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Quinapril	Quinapril Quetiapine may increase the hypotensive activities of Quinapril.
Ramipril	Ramipril Ramipril may increase the hypotensive activities of Quetiapine.
Simvastatin	Simvastatin The metabolism of Quetiapine can be decreased when combined with Simvastatin.
Amlodipine	Amlodipine Amlodipine may increase the hypotensive activities of Quetiapine.
Teniposide Injection	Teniposide Injection The metabolism of Quetiapine can be decreased when combined with Teniposide.
Itraconazole	Itraconazole The serum concentration of Quetiapine can be increased when it is combined with Itraconazole.
Lisinopril	Lisinopril Lisinopril may increase the hypotensive activities of Quetiapine.
Oxaprozin	Oxaprozin Oxaprozin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Sotalol	Sotalol The metabolism of Sotalol can be decreased when combined with Quetiapine.
Bisoprolol	Bisoprolol Bisoprolol may increase the hypotensive activities of Quetiapine.
Zolpidem	Zolpidem Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Doxazosin	Doxazosin Doxazosin may increase the hypotensive activities of Quetiapine.
Terazosin	Terazosin Terazosin may increase the hypotensive activities of Quetiapine.
Isradipine	Isradipine Isradipine may increase the hypotensive activities of Quetiapine.
Omeprazole	Omeprazole The metabolism of Quetiapine can be decreased when combined with Omeprazole.
Cisapride	Cisapride The risk or severity of QTc prolongation can be increased when Cisapride is combined with Quetiapine.
Gabapentin	Gabapentin The risk or severity of adverse effects can be increased when Gabapentin is combined with Quetiapine.
Fluvastatin	Fluvastatin The metabolism of Quetiapine can be decreased when combined with Fluvastatin.
Venlafaxine	Venlafaxine The metabolism of Quetiapine can be decreased when combined with Venlafaxine.
Nizatidine	Nizatidine The therapeutic efficacy of Quetiapine can be decreased when used in combination with Nizatidine.
Fluvoxamine	Fluvoxamine The metabolism of Quetiapine can be decreased when combined with Fluvoxamine.
Nefazodone	Nefazodone The serum concentration of Quetiapine can be increased when it is combined with Nefazodone.
Lamotrigine	Lamotrigine The risk or severity of adverse effects can be increased when Lamotrigine is combined with Quetiapine.
Losartan	Losartan Losartan may increase the hypotensive activities of Quetiapine.
Valacyclovir	Valacyclovir Valaciclovir may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Tramadol	Tramadol The risk or severity of serotonin syndrome can be increased when Tramadol is combined with Quetiapine.
Vinorelbine Injection	Vinorelbine Injection The metabolism of Quetiapine can be decreased when combined with Vinorelbine.
Carboplatin Injection	Carboplatin Injection Carboplatin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Moexipril	Moexipril Moexipril may increase the hypotensive activities of Quetiapine.
Lansoprazole	Lansoprazole The metabolism of Quetiapine can be decreased when combined with Lansoprazole.
Ifosfamide Injection	Ifosfamide Injection The metabolism of Quetiapine can be decreased when combined with Ifosfamide.
Nicardipine	Nicardipine Nicardipine may increase the hypotensive activities of Quetiapine.
Bupropion	Bupropion The metabolism of Quetiapine can be decreased when combined with Bupropion.
Ticlopidine	Ticlopidine The metabolism of Quetiapine can be decreased when combined with Ticlopidine.
Saquinavir	Saquinavir The serum concentration of Saquinavir can be increased when it is combined with Quetiapine.
Metformin	Metformin The therapeutic efficacy of Metformin can be decreased when used in combination with Quetiapine.
Nisoldipine	Nisoldipine Nisoldipine may increase the hypotensive activities of Quetiapine.
Lamivudine	Lamivudine Lamivudine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Riluzole	Riluzole The risk or severity of adverse effects can be increased when Riluzole is combined with Quetiapine.
Amifostine Injection	Amifostine Injection The risk or severity of adverse effects can be increased when Amifostine is combined with Quetiapine.
Acarbose	Acarbose The therapeutic efficacy of Acarbose can be decreased when used in combination with Quetiapine.
Glimepiride	Glimepiride The therapeutic efficacy of Glimepiride can be decreased when used in combination with Quetiapine.
Gemcitabine Injection	Gemcitabine Injection Gemcitabine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Indinavir	Indinavir The metabolism of Quetiapine can be decreased when combined with Indinavir.
Ritonavir	Ritonavir The serum concentration of Quetiapine can be increased when it is combined with Ritonavir.
Docetaxel Injection	Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Quetiapine.
Cidofovir Injection	Cidofovir Injection Cidofovir may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Meropenem Injection	Meropenem Injection Meropenem may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Clomipramine	Clomipramine The metabolism of Quetiapine can be decreased when combined with Clomipramine.
Fosfomycin	Fosfomycin Fosfomycin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Mirtazapine	Mirtazapine Quetiapine may increase the serotonergic activities of Mirtazapine.
Trandolapril	Trandolapril Quetiapine may increase the hypotensive activities of Trandolapril.
Topiramate	Topiramate The risk or severity of hyperthermia and oligohydrosis can be increased when Quetiapine is combined with Topiramate.
Valsartan	Valsartan Quetiapine may increase the hypotensive activities of Valsartan.
Insulin Lispro Injection	Insulin Lispro Injection The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Quetiapine.
Pramipexole	Pramipexole The therapeutic efficacy of Pramipexole can be decreased when used in combination with Quetiapine.
Donepezil	Donepezil The therapeutic efficacy of Quetiapine can be decreased when used in combination with Donepezil.
Nelfinavir	Nelfinavir The metabolism of Quetiapine can be decreased when combined with Nelfinavir.
Azithromycin	Azithromycin The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Quetiapine.
Loratadine	Loratadine Quetiapine may increase the anticholinergic activities of Loratadine.
Carvedilol	Carvedilol Carvedilol may increase the hypotensive activities of Quetiapine.
Nilutamide	Nilutamide Nilutamide may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Flutamide	Flutamide Flutamide may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Selegiline	Selegiline The risk or severity of adverse effects can be increased when Selegiline is combined with Quetiapine.
Bicalutamide	Bicalutamide The metabolism of Quetiapine can be decreased when combined with Bicalutamide.
Sertraline	Sertraline The risk or severity of adverse effects can be increased when Sertraline is combined with Quetiapine.
Propafenone	Propafenone The metabolism of Quetiapine can be decreased when combined with Propafenone.
Irbesartan	Irbesartan Irbesartan may increase the hypotensive activities of Quetiapine.
Tamsulosin	Tamsulosin Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Ropinirole	Ropinirole The therapeutic efficacy of Ropinirole can be decreased when used in combination with Quetiapine.
Finasteride	Finasteride The metabolism of Quetiapine can be decreased when combined with Finasteride.
Cefepime Injection	Cefepime Injection Cefepime may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cefprozil	Cefprozil Cefprozil may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cefpodoxime	Cefpodoxime Cefpodoxime may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cetirizine	Cetirizine Cetirizine may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Paroxetine	Paroxetine The metabolism of Quetiapine can be decreased when combined with Paroxetine.
Tolcapone	Tolcapone The therapeutic efficacy of Tolcapone can be decreased when used in combination with Quetiapine.
Citalopram	Citalopram The risk or severity of QTc prolongation can be increased when Citalopram is combined with Quetiapine.
Capecitabine	Capecitabine Capecitabine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Efavirenz	Efavirenz The serum concentration of Quetiapine can be increased when it is combined with Efavirenz.
Abacavir	Abacavir Abacavir may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Sildenafil	Sildenafil The risk or severity of hypotension, dyspepsia, and headache can be increased when Sildenafil is combined with Quetiapine.
Pioglitazone	Pioglitazone The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Quetiapine.
Celecoxib	Celecoxib The metabolism of Quetiapine can be decreased when combined with Celecoxib.
Rosiglitazone	Rosiglitazone The metabolism of Quetiapine can be decreased when combined with Rosiglitazone.
Tolterodine	Tolterodine The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Quetiapine.
Thalidomide	Thalidomide Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Oseltamivir	Oseltamivir Oseltamivir may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Balsalazide	Balsalazide Balsalazide may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Nateglinide	Nateglinide The therapeutic efficacy of Quetiapine can be decreased when used in combination with Nateglinide.
Galantamine	Galantamine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Quetiapine.
Levetiracetam	Levetiracetam Levetiracetam may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Rabeprazole	Rabeprazole Rabeprazole may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Terbinafine	Terbinafine The metabolism of Quetiapine can be decreased when combined with Terbinafine.